On Demand 2019 ACAAI ASM Sunday Sessions
This collection covers general sessions from Sunday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:
- Pediatric Asthma: Where Are We Going?
- Modifying Our Approach
- 7 for 11: Hot Topics in Pediatric A/I – A Joint Presentation from AAP-SOAI & ACAAI
- Primary Immune Deficiency: Optimal Care for Optimal Outcomes
- USP 797, The Final Word. What Does it Say? What Does it Mean? What Do I have to Do?
- Filling the Gaps - The Allergist's Role in Coordinating Care Across Age Groups
- Recurrent Infections with Normal or Near Normal Immunoglobulins: Now What?
- WAO World Allergy Forum: New Frontiers in Atopic Dermatitis
- How to Implement a Penicillin Allergy Program in Your Community
- Telemedicine for the Allergist
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 14 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 6 credits as meeting the requirements for MOC Part II Self-Assessment.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Use data on how changes in the indoor and outdoor environment can improve pediatric asthma control.
- Know when to use biologics and which biologics can benefit the child with moderate to severe asthma.
- Have a plan to implement step-down treatment in the child with stable asthma.
- Utilize evidence-based treatment options for patient’s refractory to standard asthma management.
- Identify risk factors associated with development of allergic conditions.
- Identify current knowledge gaps regarding how the microbiome is associated with development of allergic conditions.
- Discuss current evidence regarding treatment options surrounding the microbiome with patients who have allergic conditions.
- Identify long term prognosis markers for primary immune deficiencies and maximize life expectancy.
- Identify new infectious threats to patients with primary immune deficiencies.
- Recognize the burden of care for patients with primary immune deficiencies.
- Describe the new USP 797 standards.
- Explain the implications of the new standards.
- Describe how to make their mixing lab compliant.
- Assist care transition from adolescence to adulthood.
- Develop a plan to facilitate wellness assessments.
- Be aware of wellness concerns for aging.
- Determine when infections are due to immune deficiency or other conditions.
- Describe approach and evaluation for patients with recurrent infections, including what diagnostic testing is indicated.
- Describe management strategies and evidence-based care.
- Identify phenotypes of atopic dermatitis and discuss its role as a cause of allergic diseases.
- Report recent advances on the pathophysiology of atopic dermatitis and review current and future potential therapies based on new research.
- List advances of ICD-11 for skin conditions and explain how the ICD-11 can impact epidemiological data and the burden of skin conditions.
- Develop talking points to help primary care physicians and patients better understand penicillin allergy.
- Utilize established resources to work with local hospitals in the development of penicillin allergy reconciliation programs.
- Utilize non-allergist healthcare professionals in the assessment of patient-reported penicillin allergy.
- Set up a telemedicine service in an allergy practice.
- Use a direct-to-consumer platform to see allergy patients.
- See allergy patients using telemedicine. Change the way patients are seen using telemedicine.
William C. Anderson, MD
Ignacio J. Ansotegui, MD, PhD
Syed H. Arshad, MBBS, DM
Leonard Bacharier, MD
Sami L. Bahna, MD, DrPH, FACAAI
Mark M. Ballow, MD, FACAAI
J. Andrew Bird, MD, FACAAI
Kimberly G. Blumenthal, MD, MSc
Ivan Chinn, MD
Mark L. Corbett, MD, FACAAI
Jonathan Corren, MD, FACAAI
Carla M. Davis, MD, FACAAI
Motohiro Ebisawa, MD, PhD
Tania Elliott, MD, FACAAI
Mary B. Fasano, MD, MSPH, FACAAI
Lisa R. Forbes, MD
Alan B. Goldsobel, MD, FACAAI
Richard G. Gower, MD, FACAAI
Justin C. Greiwe, MD, FACAAI
Ruchi Gupta, MD, MPH
Angela D. Hogan, MD, FACAAI
David A. Khan, MD, FACAAI
David M. Lang, MD, FACAAI
Todd A. Mahr, MD, FACAAI
Kelly M. Maples, MD, FACAAI
J. Allen Meadows, MD, FACAAI
Mervat Nassef, MD, FACAAI
Paul O'Byrne, MD
Purvi S. Parikh, MD
Kenneth Paris, MD, MPH
Elena E. Perez, MD
Jay M. Portnoy, MD, FACAAI
Susan Prescott, MD, PhD
Allison C. Ramsey, MD, FACAAI
Matthew Rank, MD, FACAAI
Erika Gonzalez Reyes, MD, FACAAI
Mario A. Sanchez-Borges, MD
Jennifer Shih, MD
David R. Stukus, MD, FACAAI
James L. Sublett, MD, FACAAI
J. Wesley Sublett, MD, MPH, FACAAI
Luciana K. Tanno, MD, PhD
James M. Tracy, DO, FACAAI
Carina Venter, PhD, RD
Dana V. Wallace, MD, FACAAI
Julie Wang, MD, FACAAI
Richard L. Wasserman, MD, PhD, FACAAI
- 14.00 AMA PRA Category 1 Credit™
- 14.00 Attendance
- 14.00 CBRN
- 6.00 MOC